Advancing global health: UC Davis test identifies active, infectious form of TB
Invalid Access Key! Invalid Access Key!
Featured Post
2022 ACC/AHA Guideline for the Diagnosis and Management of ...
Chronic Thromboembolic Pulmonary Hypertension
1. Hoeper MM, Madani MM, Nakanishi N, Meyer B, Cebotari S, Rubin LJ: Chronic thromboembolic pulmonary hypertension. Lancet Respir Medicine 2014; 2: 573–82. CrossRef MEDLINE 2. Riedel M, Stanek V, Widimsky J, Prerovsky I: Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest 1982; 81: 151–8. CrossRef MEDLINE 3. Becattini C, Agnelli G, Pesavento R, et al.: Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. Chest 2006; 130: 172–5. CrossRef MEDLINE 4. Pengo V, Lensing AW, Prins MH, et al.: Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004; 350: 2257–64. MEDLINE MEDLINE 5. Pepke-Zaba J, Delcroix M, Lang I, et al.: Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation 2011; 124: 1973–81. CrossRef MEDLINE 6. Bonderman D, Wilkens H, Wakounig S, et al.: Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J 2009; 33: 325–31. CrossRef MEDLINE 7. Lang IM, Pesavento R, Bonderman D, Yuan JX: Risk factors andbasic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur Respir J 2013; 41: 462–8. CrossRef MEDLINE 8. Moser KM, Bloor CM: Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest 1993; 103: 685–92. CrossRef MEDLINE 9. Delcroix M, Vonk Noordegraaf A, Fadel E, Lang I, Simonneau G, Naeije R: Vascular and right ventricular remodelling in chronic thromboembolic pulmonary hypertension. Eur Respir J 2013; 41: 224–32. CrossRef MEDLINE 10. Lang IM, Madani M: Update on chronic thromboembolic pulmonary hypertension. Circulation 2014; 130: 508–18. CrossRef MEDLINE 11. Otero R, Oribe M, Ballaz A, et al.: Echocardiographic assessment of pulmonary arterial pressure in the follow-up of patients with pulmonary embolism. Thromb Res 2011; 127: 303–8. CrossRef MEDLINE 12. Konstantinides S, Torbicki A, Agnelli G, et al.: 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. The task force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC) endorsed by the European Respiratory Society (ERS). Eur Heart J 2014; pii: ehu283 [Epub ahead of print]. 13. Galie N, Hoeper MM, Humbert M, et al.: Guidelines for the diagnosis and treatment of pulmonary hypertension. The task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Respir J 2009; 34: 1219–63. MEDLINE 14. Surie S, Gibson NS, Gerdes VE, et al.: Active search for chronic thromboembolic pulmonary hypertension does not appear indicated after acute pulmonary embolism. Thromb Res 2010; 125: e202–5. CrossRef MEDLINE 15. Klok FA, Surie S, Kempf T, et al.: A simple non-invasive diagnostic algorithm for ruling out chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. Thromb Res 2011; 128: 21–6. CrossRef MEDLINE 16. Scheidl SJ, Englisch C, Kovacs G, et al.: Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients. Eur Respir J 2012; 39: 119–24. CrossRef MEDLINE 17. Held M, Grun M, Holl R, et al.: Cardiopulmonary exercise testing to detect chronic thromboembolic pulmonary hypertension in patients with normal echocardiography. Respiration 2014; 87: 379–87. MEDLINE 18. Tunariu N, Gibbs SJ, Win Z, et al.: Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med 2007; 48: 680–4. CrossRef MEDLINE 19. Kerr KM, Auger WR, Fedullo PF, Channick RH, Yi ES, Moser KM: Large vessel pulmonary arteritis mimicking chronic thromboembolic disease. Am J Respir Crit Care Med 1995; 152: 367–73. CrossRef MEDLINE 20. Bailey CL, Channick RN, Auger WR, et al.: „High probability" perfusion lung scans in pulmonary venoocclusive disease. Am J Respir Crit Care Med 2000; 162: 1974–8. CrossRef MEDLINE 21. Kauczor HU, Schwickert HC, Mayer E, Kersjes W, Moll R, Schweden F: Pulmonary artery sarcoma mimicking chronic thromboembolic disease: computed tomography and magnetic resonance imaging findings. Cardiovasc Intervent Radiol 1994; 17: 185–9. CrossRef MEDLINE 22. Rajaram S, Swift AJ, Telfer A, et al.: 3D contrast-enhanced lungperfusion MRI is an effective screening tool for chronic thromboembolic pulmonary hypertension: results from the ASPIRE Registry. Thorax 2013; 68: 677–8. CrossRef MEDLINE 23. Hong YJ, Kim JY, Choe KO, et al.: Different perfusion pattern between acute and chronic pulmonary thromboembolism: evaluation with two-phase dual-energy perfusion CT. AJR Am J Roentgenol 2013; 200: 812–7. CrossRef MEDLINE 24. Sugiyama M, Fukuda T, Sanda Y, et al.: Organized thrombus in pulmonary arteries in patients with chronic thromboembolic pulmonary hypertension; imaging with cone beam computed tomography. Jpn J Radiol 2014; 32: 375–82. CrossRef MEDLINE 25. Nagel C, Prange F, Guth S, et al.: Exercise training improves exercise capacity and quality of life in patients with inoperable or residual chronic thromboembolic pulmonary hypertension. PloS one 2012; 7: e41603. CrossRef MEDLINE PubMed Central 26. Kim NH, Delcroix M, Jenkins DP, et al.: Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol 2013; 62: D92–9. CrossRef MEDLINE 27. Mayer E, Jenkins D, Lindner J, et al.: Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg 2011; 141: 702–10. CrossRef MEDLINE 28. Jenkins DP, Madani M, Mayer E, et al.: Surgical treatment of chronic thromboembolic pulmonary hypertension. Eur Respir J 2013; 41: 735–42. CrossRef MEDLINE 29. Madani MM, Auger WR, Pretorius V, et al.: Pulmonary endarterectomy: recent changes in a single institution's experience of more than 2,700 patients. Ann Thorac Surg 2012; 94: 97–103; discussion 103. CrossRef MEDLINE 30. Vuylsteke A, Sharples L, Charman G, et al.: Circulatory arrest versus cerebral perfusion during pulmonary endarterectomy surgery (PEACOG): a randomised controlled trial. Lancet 2011; 378: 1379–87. CrossRef MEDLINE 31. Skoro-Sajer N, Marta G, Gerges C, et al.: Surgical specimens, haemodynamics and long-term outcomes after pulmonary endarterectomy. Thorax 2014; 69: 116–22. CrossRef MEDLINE PubMed Central 32. Freed DH, Thomson BM, Berman M, et al.: Survival after pulmonary thromboendarterectomy: effect of residual pulmonary hypertension. J Thorac Cardiovasc Surg 2011; 141: 383–7. CrossRef MEDLINE 33. Jais X, D'Armini AM, Jansa P, et al.: Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension BENEFiT (Bosentan Effects in iNopErable Forms of chronic Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol 2008; 52: 2127–34. MEDLINE 34. Suntharalingam J, Treacy CM, Doughty NJ, et al.: Long-term use of sildenafil in inoperable chronic thromboembolic pulmonary hypertension. Chest 2008; 134: 229–36. CrossRef MEDLINE 35. Ghofrani HA, D'Armini AM, Grimminger F, et al.: Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med 2013; 369: 319–29. CrossRef CrossRef MEDLINE 36. Feinstein JA, Goldhaber SZ, Lock JE, Ferndandes SM, Landzberg MJ: Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation 2001; 103: 10–3. CrossRef MEDLINE 37. Kataoka M, Inami T, Hayashida K, et al.: Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circulation Cardiovascular interventions 2012; 5: 756–62. CrossRef MEDLINE 38. Mizoguchi H, Ogawa A, Munemasa M, Mikouchi H, Ito H, Matsubara H: Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circulation Cardiovascular Interventions 2012; 5: 748–55. CrossRef MEDLINE 39. Sugimura K, Fukumoto Y, Satoh K, et al.: Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension. Circ J 2012; 76: 485–8. CrossRef MEDLINE 40. Fukui S, Ogo T, Morita Y, et al.: Right ventricular reverse remodelling after balloon pulmonary angioplasty. Eur Respir J 2014; 43: 1394–402. CrossRef MEDLINEPulmonary Embolism/Thromboendarterectomy
MissionChronic thromboembolic pulmonary hypertension (CTEPH) is an unusual and progressive disease that causes pulmonary arterial occlusion, gas exchange impairment, right heart failure and eventually death in 3-5 years if left untreated. The disease is sufficiently uncommon and presenting symptoms non-specific that most individual practitioners do not have sufficient patients to develop expertise in its management. The clinical faculty at UAB manage CTEPH by focusing primarily surgical resection, namely pulmonary thromboendarterectomy.
ObjectivesThe UAB/HSF Pulmonary Thromboendarterectomy Clinic has the following objectives: to provide comprehensive, state of the art clinical and surgical care to patients with pulmonary vascular disease due to chronic thromboembolic pulmonary hypertension (CTEPH), to serve as a regional educational resource for physicians and sub-specialty trainees in pulmonary, cardiology, radiology, pathology, anesthesia and cardiothoracic surgery, to acquire new knowledge through maintenance of a database, clinical trials, and refinement of surgical technique, and to disseminate that knowledge by way of publication and other educational activities.
About Our PracticeDrs. Keith Wille and David McGiffin complete a comprehensive clinical evaluation of all patients and a multidisciplinary team assists with the final decision to proceed with any surgery. Follow up after the operation includes monitoring of hemodynamic recovery and return of exercise capacity. Patients who are not surgical candidates are referred to the Pulmonary Hypertension and Lung Transplant Clinics at UAB to discuss alternative treatment strategies.
Contacting the Program for Pulmonary Embolism/ThromboendarterectomyFor more information, contact Keith Wille, MD via phone at (205) 934-7941 or via email at kwille@uabmc.Edu.
Pulmonary Arterial Hypertension
Alopecia
Asthma
Atopic Dermatitis
Autoimmune
Biosimilars
Breast Cancer
COPD
COVID-19
Cardiovascular
Cholangiocarcinoma
Chronic Kidney Disease
Colorectal Cancer
DLBCL
Dermatology
Diabetes
Digital Health
Duchenne Muscular Dystrophy
Employers
Epilepsy
Gastroenterology
Gene Therapy
HIV
Heart Failure
Hemophilia
Immuno-Oncology
Infectious Disease
Inflammation
Leukemia and Lymphoma
Liver
Lung Cancer
Lupus
Major Depressive Disorder
Medicare
Multiple Myeloma
Multiple Sclerosis
Myasthenia Gravis
Myelodysplastic Syndromes
Non-Small Cell Lung Cancer
Oncology
Ophthalmology
Ovarian Cancer
Parkinson Disease
Population Health
Prostate Cancer
Psoriasis
Pulmonary Arterial Hypertension
RSV
Rare Blood
Rare Disease
Reimbursement
Respiratory
Rheumatology
Skin Cancer
Sleep
Spinal Muscular Atrophy
Type 1 Diabetes
Vaccines
Women's Health
Popular Posts
Respirology | APSR Respiratory Medicine Journal
ldct :: Article Creator Taiwan's Lung Cancer Mortality Rate Drops By Lee I-chia / Staff reporter The mortality rate of lung cancer in Taiwan has declined for nine consecutive years, with early detection through screening the key to significantly improving survival rates, the Health Promotion Administration (HPA) said yesterday. Lung cancer is the leading cause of cancer-related deaths worldwide, WHO data showed. Nearly 2.5 million people were diagnosed with lung cancer in 2022 and more than 1.8 million people died from the disease, International Agency for Research on Cancer data showed. Photo courtesy of Changhua Christian Hospital In Taiwan, the standardized mortality rate of lung cancer has declined for nine consecutive years, although the disease still killed 10,348 people last year and it is the leading cause of cancer-related deaths in the nation, the HPA said. The case fatality rate is relatively high, but ...
“Black Death spread four times faster in second London outbreak - BBC Focus Magazine” plus 2 more
“Black Death spread four times faster in second London outbreak - BBC Focus Magazine” plus 2 more Black Death spread four times faster in second London outbreak - BBC Focus Magazine The Black Death: the pandemic that changed the world - In Defence of Marxism La Pestilenza: True Story of ‘Black Plague’ of 1348 - The Standard Black Death spread four times faster in second London outbreak - BBC Focus Magazine Posted: 20 Oct 2020 01:36 AM PDT The plague spread across London around four times faster in the 17th Century than it had in the 14th Century, a new study suggests. Advertisement Researchers found an acceleration in transmission between the Black Death of 1348 – estimated to have wiped out more than one-third of the population of Europe – and later epidemics, which culminated in the Great Plague of 1665. As well as the epidemics in the 14th and 17th Centuries, there were 18 ot...
“Teaching a pandemic in real time, part 2 . Princeton professors share how they incorporate the study - Princeton University” plus 1 more
“Teaching a pandemic in real time, part 2 . Princeton professors share how they incorporate the study - Princeton University” plus 1 more Teaching a pandemic in real time, part 2 . Princeton professors share how they incorporate the study - Princeton University Posted: 28 Jun 2021 09:09 AM PDT The pandemic changed not only how Princeton University students were learning after the transition to remote teaching in March 2020, but also what they were learning — especially as the impact of COVID-19 opened new lines of humanistic and scientific inquiry across fields of study. In this second installment about teaching the pandemic in real time ( read part one ), Princeton professors share how they incorporated the coronavirus and the pandemic's effects into their course material during the spring 2021 semester. The Art & Archaeology of Plague Janet Kay, lecturer in art and archaeology Is this a new course or an existing course...
Comments
Post a Comment